These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1036616)

  • 1. [Five years treatment of advanced solid malignomas with a combination of four cytostatic drugs (author's transl)].
    Siebner H; Weber W
    Osterr Z Onkol; 1976 May; 3(1-2):8-26. PubMed ID: 1036616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination antimetabolite-alkylating agent-vinblastine in the treatment of advanced breast cancer].
    Pipino G; Germiniani R; Lavorato F
    Minerva Med; 1977 Mar; 68(13):835-7. PubMed ID: 321990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytostatic therapy of inoperable carcinomas].
    Baumgartner G
    Wien Med Wochenschr; 1976 Jan; 126(5):59-61. PubMed ID: 986106
    [No Abstract]   [Full Text] [Related]  

  • 4. [The combined treatment of bronchial carcinoma (author's transl)].
    Pridun N; Karrer K
    MMW Munch Med Wochenschr; 1975 Aug; 117(31):1273-8. PubMed ID: 180405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experiences with cytostatic treatment of malignant tumors].
    Siering H; Felsch G; Barthel E
    Z Gesamte Inn Med; 1976 Feb; 31(3):65-9. PubMed ID: 960897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G; Kratzer H; Denz H; Huber H
    Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of high-dosage attack treatment with cytostatics in mammary and ovarian cancer (author's transl)].
    Möhlen KH; Beller FK
    Strahlentherapie; 1978 Sep; 154(9):622-6. PubMed ID: 684782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Registration of cytostatic effects on cultured cells in vitro and their current significance for individualized chemotherapy of tumors in advanced ovarian carcinoma].
    Ebeling K; Spitzbart H
    Zentralbl Gynakol; 1977; 99(17):1041-54. PubMed ID: 579017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone.
    Tannir N; Yap HY; Hortobagyi GH; Hug V; Buzdar AU; Blumenschein GR
    Cancer Treat Rep; 1984; 68(7-8):1039-41. PubMed ID: 6547638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sequential chemotherapy based on the hypothesis of a circadian rhythm of tumor proliferation].
    Focan C
    Nouv Presse Med; 1975 Nov; 4(38):2709-12. PubMed ID: 1105421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polychemotherapy of the advanced and metastasizing carcinoma of the breast].
    Riedler L
    Fortschr Med; 1976 May; 94(13):761-4. PubMed ID: 955536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experiences with a combination therapy of metastasising genital and mammary carcinomas (author's transl)].
    Brachetti A; Leonhardt A; Limburg H; Osswald H; Schmähl D
    MMW Munch Med Wochenschr; 1974 Nov; 116(47):2037-42. PubMed ID: 4216809
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intermittent cytostatic intensive therapy of solid tumors with a combination of four drugs].
    Siebner H; Hackethal L
    Med Welt; 1973 Feb; 24(5):166-9. PubMed ID: 4617091
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical controlled trial in advanced breast cancer: CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CMF + T (cyclophosphamide, methotrexate, 5-fluorouracil, tamoxifen). CMEA Cooperative Treatment Group.
    Neoplasma; 1985; 32(3):381-7. PubMed ID: 2862594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CMF (cyclophosphamide, methotrexate, ftorafur) chemotherapy in advanced breast cancer].
    Gottwald G; Szakolczai I
    Orv Hetil; 1983 Jan; 124(2):79-84. PubMed ID: 6687491
    [No Abstract]   [Full Text] [Related]  

  • 17. First, second and third line chemotherapy programs in metastatic breast carcinoma.
    Rizel S; Sulkes A; Gez E; Brufman G; Biran S
    Isr J Med Sci; 1981; 17(9-10):946-53. PubMed ID: 6171542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III study.
    Pannuti F; Iafelice G; Martoni A; Fruet F; Angelelli B; Casadei M
    Chemioterapia; 1984 Aug; 3(4):216-9. PubMed ID: 6398121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both].
    Clavel B; Cappelaere JP; Guerin J; Klein T; Pommatau E; Berlie J
    Sem Hop; 1982 Sep; 58(34):1919-23. PubMed ID: 6293073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
    Bustová I
    Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.